RT Journal Article
SR Electronic
T1 FHIR-GPT Enhances Health Interoperability with Large Language Models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.17.23297028
DO 10.1101/2023.10.17.23297028
A1 Li, Yikuan
A1 Wang, Hanyin
A1 Yerebakan, Halid Z.
A1 Shinagawa, Yoshihisa
A1 Luo, Yuan
YR 2023
UL http://medrxiv.org/content/early/2023/11/10/2023.10.17.23297028.abstract
AB Advancing health interoperability can significantly benefit health research, including phenotyping, clinical trial support, and public health surveillance. Federal agencies, including ONC, CDC, and CMS, have been collectively collaborating to promote interoperability by adopting Fast Healthcare Interoperability Resources (FHIR). However, the heterogeneous structures and formats of health data present challenges when transforming Electronic Health Record (EHR) data into FHIR resources. This challenge becomes more significant when critical health information is embedded in unstructured data rather than well-organized structured formats. Previous studies relied on multiple separate rule-based or deep learning-based NLP tools to complete the FHIR resource transformation, which demands substantial development costs, extensive training data, and meticulous integration of multiple individual NLP tools. In this study, we assessed the ability of large language models (LLMs) to transform clinical narratives into HL7 FHIR resources. Our experiments on 3,671 snippets of clinical texts demonstrate that the best-performing LLM, namely FHIR-GPT, achieves an exceptional exact match rate of over 90% in the transformation to FHIR medicationstatement resources, when compared to human annotations. FHIR-GPT improved the exact match rates of existing NLP pipelines by 3% for routes, 12% for dose quantities, 35% for reasons, 42% for forms, and over 50% for timing schedules. Our findings provide the foundations for leveraging LLMs to enhance health data interoperability. Future studies will aim to build upon these successes by extending the generation to additional FHIR resources.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was conducted when Yikuan Li is a research intern at Siemens Healthineers.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All datasets are publicly available at https://mimic.mit.edu/docs/iii/ https://portal.dbmi.hms.harvard.edu/projects/n2c2-nlp/ I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yeshttps://mimic.mit.edu/docs/iii/ https://portal.dbmi.hms.harvard.edu/projects/n2c2-nlp/